alexandra brand of syngenta thank you very much. coming up at 10:30 a.m. in new york, kevin johnson, the starbucks ceo will be joining us. this is bloomberg. ♪ alix: s&p futures are searching. gillyve study is coming out well despite the fact that the first quarter gdp looks bad and personal consumption is bad. this is bloomberg. ♪ ♪ jonathan: from new york city for our audience worldwide, the countdown to the open starts right now. here is your wednesday morning price action. 30 minutes out from the opening bell it is risk on. two big pillars. equity futures up one .9% on the s&p 500. mega caps and tech stocks getting a lift on the back of alphabet earnings. in the last 30 minutes we have positive data from gilead on the drug trial. that gives equities a lift and leaves treasuries unchanged and a dollar weaker against the bulk of g10 through much of this morning and then some. let's begin with the big issue this morning, the economic data. end of data marks the the longest expansion on record for the american economy after the beginning of a recession in america. the focus of this market is on the path of the recovery, not the recession we are in right now. let's get straight to